| CXSB2300062 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(1) | Supplementary Application | 2023-06-10 | | | | | view |
| CXSB2200057 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(原2) | Supplementary Application | 2022-06-30 | | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | | | view |
| CXSB2200026 | 重组人源化抗VEGF单克隆抗体眼用注射液 | | Injection | Biological Products(原2) | Supplementary Application | 2022-02-28 | | SinoCelltech Ltd | | | view |
| CXSB2200005 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(1) | Supplementary Application | 2022-01-17 | | | | | view |
| CXSL2101433 | 重组人源化抗VEGF单克隆抗体注射液 | | Injection | Biological Products(2.2) | New Drug Application | 2021-11-22 | | SinoCelltech Ltd | | | view |
| CXSB2101028 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products | Supplementary Application | 2021-07-26 | | Jiangsu T-mab Bio-Pharmaceuticals Co Ltd | | | view |
| CXSB2101027 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products | Supplementary Application | 2021-07-26 | | Jiangsu T-mab Bio-Pharmaceuticals Co Ltd | | | view |
| CXSB2100008 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(1) | Supplementary Application | 2021-01-29 | 上海复宏汉霖生物技术股份有限公司；上海复宏汉霖生物制药有限公司 | | In Review | 2021-01-28 | view |
| CXSL2000157 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2020-07-09 | 东莞市东阳光单抗生物药有限公司 | Dongguan Dongyangguang Monoclonal Antibody Biological Drug Co Ltd | In Review | 2020-07-07 | view |
| CXSL2000119 | 重组人源化抗VEGF单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2020-05-29 | 神州细胞工程有限公司 | SinoCelltech Ltd | In Review | 2020-05-28 | view |
| CXSL1900134 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(1) | New Drug Application | 2019-12-03 | 百奥泰生物制药股份有限公司 | Bio-Thera Solutions Ltd | In Review | 2019-12-02 | view |
| CXSB1900019 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products | Supplementary Application | 2019-08-13 | 江苏泰康生物医药有限公司 | Jiangsu T-mab Bio-Pharmaceuticals Co Ltd | Certificate Issued | 2020-03-06 | view |
| CXSL1800131 | 重组人源化抗VEGF单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2019-01-07 | 百奥泰生物科技（广州）有限公司 | Bio-Thera Solutions Ltd | In Review | 2019-01-04 | view |
| CXSL1800124 | 重组人源化抗VEGF单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2018-12-25 | 百奥泰生物科技（广州）有限公司 | Bio-Thera Solutions Ltd | In Review | 2018-12-24 | view |
| CXSB1800008 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products | Supplementary Application | 2018-09-28 | 迈威（上海）生物科技有限公司 | Mabwell (Shanghai) Bioscience Co Ltd | Certificate Issued | 2018-12-11 | view |
| CXSS1800017 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2018-08-15 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | Certificate Issued | 2019-12-11 | view |
| CXSL1800081 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2018-07-30 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2018-10-08 | view |
| CXSL1800071 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2018-07-20 | 上海复宏汉霖生物技术股份有限公司 | Shanghai Henlius Biotech Co Ltd | Certificate Issued | 2018-09-25 | view |
| CXSL1800037 | 重组人源化抗VEGF单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2018-04-19 | 喜康（武汉）生物医药有限公司 | Xikang(Wuhan)Biopharmaceutical Co Ltd | Certificate Issued | 2018-09-25 | view |
| CXSL1700156 | 重组抗VEGF人源化单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2018-02-26 | 桂林三金药业股份有限公司 | Guilin Sanjin Pharmaceutical Co Ltd | Certificate Issued | 2018-06-28 | view |
